Label: DRAMAMINE ORANGE- dimenhydrinate tablet, chewable

  • NDC Code(s): 63029-902-01, 63029-902-02
  • Packager: Medtech Products Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 25, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active ingredient

    (in each tablet)

    Dimenhydrinate 50 mg

  • Purpose

    Antiemetic

  • Use

    for prevention and treatment of these symptoms associated with motion sickness

    • nausea
    • vomiting
    • dizziness
  • Warnings

    Do not give to children under 2 years of age unless directed by a doctor

    Ask a doctor before use if you have

    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • trouble urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use

    if you are taking sedatives or tranquilizers

    When using this product

    • marked drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding,

    ask a doctor before use.

    Keep out of reach of children.

    In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    to prevent motion sickness, the first dose should be taken ½ to 1 hour before starting activity

    to prevent or treat motion sickness, see below:

    Adults and
    children 12
    years and over
    • take 1 to 2 tablets every 4-6 hours
    • do not take more than 8 chewable tablets
      in 24 hours, or as directed by a doctor
    Children 6 to
    under 12 years
    • give ½ to 1 tablet every 6-8 hours
    • do not give more than 3 chewable tablets
      in 24 hours, or as directed by a doctor
    Children 2 to
    under 6 years
    • give ½ tablet every 6-8 hours
    • do not give more than 1 ½ chewable tablets
      in 24 hours, or as directed by a doctor
  • Other information

    • Phenylketonurics: contains phenylalanine 0.84 mg per tablet
    • store at room temperature 68-77ºF (20-25ºC)
    • do not use if carton is opened or if blister is broken or torn
    • see side panel for lot number and expiration date
  • Inactive ingredients

    anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

  • Questions or comments?

    Call 1-800-382-7219




  • PRINCIPAL DISPLAY PANEL

    Dimenhydrinate Tablets/Antiemetic
    CHEWABLE FORMULA
    Dramamine®
    MOTION SICKNESS RELIEF
    DUAL ACTION
    1. TREATS SYMPTOMS ON THE SPOT
    2. PREVENTS NAUSEA, DIZZINESS & VOMITING
    Convenient Chewable Tablets
    8 ORANGE FLAVORED TABLETS (50 mg EACH)

    PRINCIPAL DISPLAY PANEL Dimenhydrinate Tablets/Antiemetic CHEWABLE FORMULA Dramamine® MOTION SICKNESS RELIEF 8 ORANGE FLAVORED TABLETS (50 mg EACH)

  • INGREDIENTS AND APPEARANCE
    DRAMAMINE ORANGE 
    dimenhydrinate tablet, chewable
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63029-902
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIMENHYDRINATE (UNII: JB937PER5C) (8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE50 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    ASPARTAME (UNII: Z0H242BBR1)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    ALUMINUM OXIDE (UNII: LMI26O6933)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    SORBITOL (UNII: 506T60A25R)  
    Product Characteristics
    ColororangeScore2 pieces
    ShapeROUNDSize12mm
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:63029-902-011 in 1 BOX01/15/2012
    18 in 1 BLISTER PACK; Type 0: Not a Combination Product
    2NDC:63029-902-022 in 1 POUCH; Type 0: Not a Combination Product01/15/2012
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00901/15/2012
    Labeler - Medtech Products Inc. (122715688)
    Establishment
    NameAddressID/FEIBusiness Operations
    Contract Pharmacal Corp.057795122analysis(63029-902) , label(63029-902) , manufacture(63029-902) , pack(63029-902)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!